Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    PubMed     Text format     Abstract available


  2. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    PubMed     Text format     Abstract available


  3. WANG H, Schmit SL, Haiman CA, Keku TO, et al
    Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30687.
    PubMed     Text format     Abstract available


  4. FIDLER MM, Bray F, Vaccarella S, Soerjomataram I, et al
    Assessing global transitions in human development and colorectal cancer incidence.
    Int J Cancer. 2017 Mar 9. doi: 10.1002/ijc.30686.
    PubMed     Text format     Abstract available


  5. KEUM N, Yuan C, Nishihara R, Zoltick E, et al
    Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30683.
    PubMed     Text format     Abstract available


    February 2017
  6. KIRANA C, Ruszkiewicz A, Stubbs RS, Hardingham JE, et al
    Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30667.
    PubMed     Text format     Abstract available


  7. JERZAK KJ, Berry S, Ko YJ, Earle C, et al
    Cetuximab plus Irinotecan versus Panitumumab in Patients with refractory metastatic colorectal cancer in Ontario, Canada.
    Int J Cancer. 2017 Feb 21. doi: 10.1002/ijc.30637.
    PubMed     Text format     Abstract available


  8. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    PubMed     Text format     Abstract available


  9. FASANELLI F, Zugna D, Giraudo MT, Krogh V, et al
    Abdominal adiposity is not a mediator of the protective effect of Mediterranean Diet on colorectal cancer.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30653.
    PubMed     Text format     Abstract available


  10. CUBIELLA J, Digby J, Rodriguez-Alonso L, Vega P, et al
    The FAST (Faecal Haemoglobin Concentration, Age and Sex Test) Score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30639.
    PubMed     Text format     Abstract available


    January 2017
  11. HERBST A, Vdovin N, Gacesa S, Philipp A, et al
    Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30625.
    PubMed     Text format     Abstract available


  12. WALTER V, Jansen L, Knebel P, Chang-Claude J, et al
    Physical activity and survival of colorectal cancer patients: Population-based study from Germany.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30619.
    PubMed     Text format     Abstract available


    December 2016
  13. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    PubMed     Text format     Abstract available


  14. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
    Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
    PubMed     Text format     Abstract available


  15. MORI K, Toiyama Y, Otake K, Fujikawa H, et al
    Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30557.
    PubMed     Text format     Abstract available


  16. WANG C, Wang Z, Zhou J, Liu S, et al
    TUC.338 promotes invasion and metastasis in colorectal cancer.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30542.
    PubMed     Text format     Abstract available


    November 2016
  17. BURON PUST A, Alison R, Blanks R, Pirie K, et al
    Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
    Int J Cancer. 2016 Nov 18. doi: 10.1002/ijc.30527.
    PubMed     Text format     Abstract available


  18. ALGARS A, Sundstrom J, Lintunen M, Jokilehto T, et al
    EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30507.
    PubMed     Text format     Abstract available


  19. CHEN Y, Xie Y, Xu L, Zhan S, et al
    Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30496.
    PubMed     Text format     Abstract available


    October 2016
  20. MOMEN-HERAVI F, Babic A, Tworoger SS, Zhang L, et al
    Periodontal disease, tooth loss, and colorectal cancer risk: Results from the Nurses' Health Study.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30486.
    PubMed     Text format     Abstract available


  21. WANG N, Khankari NK, Cai H, Li HL, et al
    Pre-diagnosis Body Mass Index and Waist-Hip Circumference Ratio in Association with Colorectal Cancer Survival.
    Int J Cancer. 2016 Oct 5. doi: 10.1002/ijc.30459.
    PubMed     Text format     Abstract available


    September 2016
  22. SCLAFANI F, Kim TY, Cunningham D, Kim TW, et al
    Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30453.
    PubMed     Text format     Abstract available


  23. SIMONS CC, Schouten LJ, Godschalk RW, van Engeland M, et al
    Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
    Int J Cancer. 2016 Sep 20. doi: 10.1002/ijc.30439.
    PubMed     Text format     Abstract available


  24. MAIERTHALER M, Benner A, Hoffmeister M, Surowy H, et al
    Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30433.
    PubMed     Text format     Abstract available


  25. VAN ERNING FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, et al
    Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30423.
    PubMed     Text format     Abstract available


  26. PARK C, Kim JI, Hong SN, Jung HM, et al
    A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
    Int J Cancer. 2016 Sep 8. doi: 10.1002/ijc.30421.
    PubMed     Text format     Abstract available


    August 2016
  27. PENG F, Hu D, Lin X, Chen G, et al
    Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30404.
    PubMed     Text format     Abstract available


  28. LI Q, Wei P, Huang B, Xu Y, et al
    MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30388.
    PubMed     Text format     Abstract available


  29. TAKAHASHI Y, Sugai T, Habano W, Ishida K, et al
    Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30377.
    PubMed     Text format     Abstract available


    July 2016
  30. JARY M, Lecomte T, Bouche O, Kim S, et al
    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
    PubMed     Text format     Abstract available


  31. SALIMZADEH H, Bishehsari F, Amani M, Ansari R, et al
    Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-based Study.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30366.
    PubMed     Text format     Abstract available


  32. ZHANG X, Keum N, Wu K, Smith-Warner SA, et al
    Calcium intake and colorectal cancer risk: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jul 28. doi: 10.1002/ijc.30293.
    PubMed     Text format     Abstract available


  33. WEIGL K, Jansen L, Chang-Claude J, Knebel P, et al
    Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30284.
    PubMed     Text format     Abstract available


  34. SOREIDE K
    Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.
    Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30244.
    PubMed     Text format    


  35. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
    Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
    PubMed     Text format     Abstract available


    June 2016
  36. KANTOR ED, Zhang X, Wu K, Signorello LB, et al
    Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jun 30. doi: 10.1002/ijc.30250.
    PubMed     Text format     Abstract available


  37. LAM-BOER J', Van der Geest LG, Verhoef C, Elferink ME, et al
    Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in The Netherlands.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30240.
    PubMed     Text format     Abstract available


  38. MEULENDIJKS D, Henricks LM, Amstutz U, Froehlich TK, et al
    Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
    Int J Cancer. 2016;138:2752-61.
    PubMed     Text format     Abstract available


  39. ALLAIRE JM, Roy SA, Ouellet C, Lemieux E, et al
    Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation.
    Int J Cancer. 2016;138:2700-12.
    PubMed     Text format     Abstract available


    May 2016
  40. DUFFY AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, et al
    Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30199.
    PubMed     Text format     Abstract available


  41. PARK SY, Wilkens LR, Kolonel LN, Henderson BE, et al
    Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
    Int J Cancer. 2016 May 2. doi: 10.1002/ijc.30172.
    PubMed     Text format     Abstract available


    April 2016
  42. YU J, Chen Y, Fu X, Zhou X, et al
    Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway.
    Int J Cancer. 2016 Apr 30. doi: 10.1002/ijc.30168.
    PubMed     Text format     Abstract available


  43. KOCARNIK JM, Chan AT, Slattery ML, Potter JD, et al
    Relationship of pre-diagnostic body mass index with survival after colorectal cancer: Stage-specific associations.
    Int J Cancer. 2016 Apr 28. doi: 10.1002/ijc.30163.
    PubMed     Text format     Abstract available


  44. JAYASEKARA H, Reece JC, Buchanan DD, Rosty C, et al
    Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.
    Int J Cancer. 2016 Apr 21. doi: 10.1002/ijc.30153.
    PubMed     Text format     Abstract available


  45. YOON YS, Jung S, Zhang X, Ogino S, et al
    Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-up Study cohort.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30141.
    PubMed     Text format     Abstract available


  46. VILLACIS RA, Miranda PM, Gomy I, Santos EM, et al
    Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
    Int J Cancer. 2016;138:1928-35.
    PubMed     Text format     Abstract available


  47. BERNTSSON J, Nodin B, Eberhard J, Micke P, et al
    Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
    Int J Cancer. 2016 Apr 13. doi: 10.1002/ijc.30138.
    PubMed     Text format     Abstract available


  48. PHIPPS AI, Shi Q, Limburg PJ, Nelson GD, et al
    Alcohol consumption and colon cancer prognosis among participants in North Central Cancer Treatment Group phase III trial N0147.
    Int J Cancer. 2016 Apr 8. doi: 10.1002/ijc.30135.
    PubMed     Text format     Abstract available


  49. SHIGETA K, Hasegawa H, Okabayashi K, Tsuruta M, et al
    Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer.
    Int J Cancer. 2016 Apr 7. doi: 10.1002/ijc.30127.
    PubMed     Text format     Abstract available


  50. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
    Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Int J Cancer. 2016;138:1719-31.
    PubMed     Text format     Abstract available


  51. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    PubMed     Text format     Abstract available


  52. SAKAI E, Fukuyo M, Ohata K, Matsusaka K, et al
    Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Int J Cancer. 2016;138:1634-44.
    PubMed     Text format     Abstract available


    March 2016
  53. HANYUDA A, Ogino S, Rong Qian Z, Nishihara R, et al
    Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate.
    Int J Cancer. 2016 Mar 31. doi: 10.1002/ijc.30122.
    PubMed     Text format     Abstract available


  54. OSUMI H, Shinozaki E, Suenaga M, Matsusaka S, et al
    RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
    Int J Cancer. 2016 Mar 23. doi: 10.1002/ijc.30106.
    PubMed     Text format     Abstract available


  55. SEEBER A, Untergasser G, Spizzo G, Terracciano L, et al
    Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer.
    Int J Cancer. 2016 Mar 21. doi: 10.1002/ijc.30099.
    PubMed     Text format     Abstract available


  56. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
    PubMed     Text format     Abstract available


  57. KANGWAN N, Kim YJ, Han YM, Jeong M, et al
    Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
    Int J Cancer. 2016;138:1482-93.
    PubMed     Text format     Abstract available


  58. RENAUD F, Mariette C, Vincent A, Wacrenier A, et al
    The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Int J Cancer. 2016;138:1472-81.
    PubMed     Text format     Abstract available


  59. ESPEJO-HERRERA N, Gracia-Lavedan E, Boldo E, Aragones N, et al
    Colorectal cancer risk and nitrate exposure through drinking water and diet.
    Int J Cancer. 2016 Mar 8. doi: 10.1002/ijc.30083.
    PubMed     Text format     Abstract available


  60. ABDALLAH EA, Fanelli MF, Souza E Silva V, Machado Netto MC, et al
    MRP1 expression in CTCs confers resistance to irinotecan-based treatment in metastatic colorectal cancer.
    Int J Cancer. 2016 Mar 7. doi: 10.1002/ijc.30082.
    PubMed     Text format     Abstract available


  61. GALDIERO MR, Bianchi P, Grizzi F, Di Caro G, et al
    Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer.
    Int J Cancer. 2016 Mar 3. doi: 10.1002/ijc.30076.
    PubMed     Text format     Abstract available


  62. LI Y, Jia H, Yu W, Xu Y, et al
    Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Int J Cancer. 2016 Mar 2. doi: 10.1002/ijc.30071.
    PubMed     Text format     Abstract available


  63. IZANO M, Wei EK, Tai C, Swede H, et al
    Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Int J Cancer. 2016;138:1118-28.
    PubMed     Text format     Abstract available


  64. DE CUBA EM, Snaebjornsson P, Heideman DA, van Grieken NC, et al
    Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    Int J Cancer. 2016;138:1139-45.
    PubMed     Text format     Abstract available


  65. BU Y, Li X, He Y, Huang C, et al
    A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
    Int J Cancer. 2016;138:1186-98.
    PubMed     Text format     Abstract available


    February 2016
  66. VERHOEFF SR, van Erning FN, Lemmens VE, de Wilt JH, et al
    Adjuvant chemotherapy is not associated with improved survival for all high risk factors in stage II colon cancer.
    Int J Cancer. 2016 Feb 23. doi: 10.1002/ijc.30053.
    PubMed     Text format     Abstract available


  67. ENG C, Bessudo A, Hart LL, Severtsev A, et al
    A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
    Int J Cancer. 2016 Feb 17. doi: 10.1002/ijc.30049.
    PubMed     Text format     Abstract available


  68. MEGE D, Panicot-Dubois L, Ouaissi M, Robert S, et al
    The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
    Int J Cancer. 2016;138:939-48.
    PubMed     Text format     Abstract available


  69. VAYRYNEN JP, Kantola T, Vayrynen SA, Klintrup K, et al
    The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer.
    Int J Cancer. 2016 Feb 13. doi: 10.1002/ijc.30040.
    PubMed     Text format     Abstract available


  70. KAP EJ, Seibold P, Scherer D, Habermann N, et al
    SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30026.
    PubMed     Text format     Abstract available


    January 2016
  71. HOBAUS J, Tennakoon S, Heffeter P, Groeschel C, et al
    Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.
    Int J Cancer. 2016;138:440-50.
    PubMed     Text format     Abstract available


  72. CARR PR, Walter V, Brenner H, Hoffmeister M, et al
    Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis.
    Int J Cancer. 2016;138:293-302.
    PubMed     Text format     Abstract available


  73. SUN L, Hu S, Yu L, Guo C, et al
    Serum Haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29993.
    PubMed     Text format     Abstract available


  74. FETAHU IS, Tennakoon S, Lines KE, Groschel C, et al
    miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors.
    Int J Cancer. 2016;138:137-45.
    PubMed     Text format     Abstract available


    December 2015
  75. ZHANG X, Ai F, Li X, She X, et al
    Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.
    Int J Cancer. 2015;137:2803-14.
    PubMed     Text format     Abstract available


  76. KEUM N, Cao Y, Oh H, Smith-Warner SA, et al
    Sedentary behaviors and light-intensity activities in relation to colorectal cancer risk.
    Int J Cancer. 2015 Dec 9. doi: 10.1002/ijc.29953.
    PubMed     Text format     Abstract available


  77. LEENDERS M, Siersema PD, Overvad K, Tjonneland A, et al
    Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2015;137:2705-14.
    PubMed     Text format     Abstract available


    November 2015
  78. HUYNH PT, Beswick EJ, Coronado YA, Johnson P, et al
    CD90 stromal cells are the major source of IL-6 which supports cancer stem-like cells and inflammation in colorectal cancer.
    Int J Cancer. 2015 Nov 23. doi: 10.1002/ijc.29939.
    PubMed     Text format     Abstract available


  79. SODRING M, Gunnes G, Paulsen JE
    Spontaneous initiation, promotion, and progression of colorectal cancer in the novel A/J Min/+ mouse.
    Int J Cancer. 2015 Nov 13. doi: 10.1002/ijc.29928.
    PubMed     Text format     Abstract available


  80. KUNZMANN AT, Coleman HG, Huang WY, Cantwell MM, et al
    Fruit and Vegetable Intakes and Risk of Colorectal Cancer and Incident and Recurrent Adenomas in the PLCO Cancer Screening Trial.
    Int J Cancer. 2015 Nov 11. doi: 10.1002/ijc.29922.
    PubMed     Text format     Abstract available


  81. BUTT J, Romero-Hernandez B, Perez-Gomez B, Willhauck-Fleckenstein M, et al
    Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29914.
    PubMed     Text format     Abstract available


    October 2015
  82. BOONSTRA MC, Tolner B, Schaafsma BE, Boogerd LS, et al
    Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Int J Cancer. 2015;137:1910-20.
    PubMed     Text format     Abstract available


  83. STERN C, Kasnitz N, Kocijancic D, Trittel S, et al
    Induction of CD4(+) and CD8(+) anti-tumor effector T cell responses by bacteria mediated tumor therapy.
    Int J Cancer. 2015;137:2019-28.
    PubMed     Text format     Abstract available


    September 2015
  84. LERRO CC, Koutros S, Andreotti G, Hines CJ, et al
    Use of acetochlor and cancer incidence in the Agricultural Health Study.
    Int J Cancer. 2015;137:1167-75.
    PubMed     Text format     Abstract available


    August 2015
  85. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
    High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
    PubMed     Text format     Abstract available


    June 2015
  86. ANTILL YC, Dowty JG, Ko Win A, Thompson T, et al
    Lynch Syndrome and Cervical Cancer.
    Int J Cancer. 2015 Jun 15. doi: 10.1002/ijc.29641.
    PubMed     Text format     Abstract available


    May 2015
  87. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: